Medtronic Picks Up Surgical Safety Firm In $235 Million Deal
This article was originally published in The Gray Sheet
Executive Summary
The device giant is buying RF Surgical Systems, which makes a radiofrequency-based technology to help prevent surgical sponges from being retained in a patient after a procedure. Sponge retention is a non-reimbursable "never event" under Medicare, driving hospital interest in solutions to reduce the occurrence.
You may also be interested in...
Medtronic Takes Aim At Implantable Device Infections with TYRX Buy
The $160 million cash acquisition fits with the firm’s efforts to fashion itself into a health care services and solutions company, rather than pure device firm. TYRX makes anti-bacterial envelopes for implanted devices, and has FDA clearances with cardiac implantable electronic devices and spinal cord neurostimulators.
Stay Or Exit? Global Health Players Ponder New China Trajectory
It's again the time of year when global CEOs descend on China's capital to discuss strategies. This year, however, the mood is different.
Report Finds Digital Diabetes Tools Deliver No ‘Meaningful Clinical Benefits'
A new report from health economics group the Peterson Health Technology Institute found that apps to help patients manage their blood sugar levels delivered few of the promised benefits. However, a digital therapeutics industry association says PHTI’s research cast too narrow a net.